MRSA Vaccine Shows Promise
Posted on October 31, 2006 Comments (3)
Superbug vaccine ‘shows promise’
…
The team looked for a vaccine using a technique called “reverse vaccinology”, which builds on recent genetics advances.
It involved sifting through the genome of Staphylococcus aureus to hunt for proteins on the microbe that might spark the body’s immune system into action, producing protection against the bacteria.
The team identified four proteins that prompted a strong immune response, making them good targets for vaccines.
Related: CDC Urges Increased Effort to Reduce Drug-Resistant Infections – Entirely New Antibiotic Developed – Drug Resistant Bacteria More Common
More information on MRSA is available from the United States Center for Disease Control and Prevention.
3 Responses to “MRSA Vaccine Shows Promise”
Leave a Reply
November 9th, 2007 @ 9:07 am
“This vaccine can be produced in giant vats of living cells. Such a production method means it can be scaled up much faster than egg-based vaccines, making it more useful in a pandemic. Several versions have been tested successfully in people…”
November 12th, 2007 @ 12:52 am
“This elegant work helps reveal the complex strategy that S. aureus has developed to evade our normal immune defenses…”
March 7th, 2008 @ 11:15 am
“immunization with a stabilized version of a protein found on Streptococcus bacteria can provide protection against Strep infections, which afflict more than 600 million people each year and kill 400,000…”